Iraj Nikfarjam, MD
Neuroradiology · Ocala, FLNPI 1376603803
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,208 of the $5,285 with a category attached, or 60.7%. 8 manufacturers reported payments, led by Penumbra, Inc. at 56.1% of the total. Reporting peaked in 2024 at $2,435 and has fallen 90.0% since, to $244 in 2025.
Across 52 payments — averaging $101.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$3K
- Imperative Care, Inc$1K
- Medtronic$844
- Johnson & Johnson$126
- Microvention, Inc.$95
- Boston Scientific$90
- plus $41 from 2 others
What the payments were for
- Travel & lodging$3,20861%
- Food & beverage$2,07739%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 10 | $2,964 |
| Imperative Care, Inc | 11 | $1,125 |
| Medtronic(3 entities) | 18 | $844 |
| Johnson & Johnson | 5 | $126 |
| Microvention, Inc. | 5 | $95 |
| Boston Scientific | 1 | $90 |
| UCB, Inc. | 1 | $21 |
| AstraZeneca | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$2,665
- ZOOM 88-T LARGE DISTAL PLATFORM$928
- Pipeline$523
- RED 72$119
How this compares
$5,285 in reported general payments places this provider in the 75th percentile of 50 neuroradiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other neuroradiology in Ocala
- Luis VacaOcala$8K
- Soma Sinha RoyOcala$2K
- Guilherme DabusMiami$438K
- Italo LinfanteMiami$275K
- Brijesh MehtaHollywood$60K
- Lowell DawsonSt Petersburg$55K
- Jimmy GhostineAventura$38K
- Gerard DeibThe Villages$17K
- Richard KlucznikTampa$13K
- Laszlo MiskolcziFt Lauderdale$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.